ANGELA CONLEY: Open Payments
NPI 1407376734 · URBANDALE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,710 in 92 payments from 21 companies in 2025. Trend: 2023 $633 · 2024 $1,983 · 2025 $1,710
Food & beverage: $1,691Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $359 |
| PFIZER INC. | 16 | $242 |
| ABBVIE INC. | 11 | $155 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $102 |
| Novo Nordisk Inc | 4 | $84 |
| Exact Sciences Corporation | 4 | $79 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 5 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
Products named: FARXIGA, Kerendia, UBRELVY, JARDIANCE, NURTEC ODT, REXULTI, PREVNAR 20, XIFAXAN.
Industry payments across IA — which companies pay providers there.
